Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201407206063N3
IRCT201407206063N3
Completed
Phase 2

Administration of bolus follicle stimulating hormone (FSH) with trigger dose human chorionic gonadotropin (hCG) in prevention of ovarian hyperstimulation syndrom (OHSS)

Tehran University of Medical Science and Health Service0 sites70 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOHSS.Hyperstimulation of ovaries

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
OHSS.
Sponsor
Tehran University of Medical Science and Health Service
Enrollment
70
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Tehran University of Medical Science and Health Service

Eligibility Criteria

Inclusion Criteria

  • •25 to 40 years old woman;under a long agonist suppression IVF protocol at infertility department of Shariati hospital; with \>20 follicles in ART cycles ultrasonography, exclusion criteria:?no trend to contribution.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatio
ISRCTN14825568VU University Medical Centre (VUMC) (Netherlands)80
Completed
Not Applicable
The role of inactive follicle stimulating hormone in ovarian dysfunction in galactosemia.infertility in galactosemia (inherited metabolic disorder)100147011002160510033283
NL-OMON31697Academisch Ziekenhuis Maastricht20
Not yet recruiting
Phase 4
Prostaglandins or balloon for induction of labour at terminduction of labour10010273
NL-OMON32572Academisch Medisch Centrum812
Completed
Not Applicable
Study of injection of follicular fluid into uterine cavity on implantation rate in IVF cycleInfertility.Female infertility associated with anovulation
IRCT2015021713566N3Vice chancellor for Research,Tabriz University of Medical Sciences110
Active, not recruiting
Phase 1
uteal phase ovarian stimulation with Follitropin delta and dydrogesteroneVolutary women who wish to donate their oocytesTherapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
CTIS2024-513998-48-00niversitair Ziekenhuis Brussel50